Name:
Cyston.
Description:
: Round, biconvex, light brown tablets with lighter and darker patches. Release form Tablets. Special instructions Since the therapeutic effect of the drug Cyston® develops gradually, you should stop taking it if you experience acute pain in the kidneys and urinary tract and consult a doctor. The use of the drug in urolithiasis requires a diet with a restriction in the diet of nutrients that contribute to the formation of salt crystals or stones in the urinary tract, and taking into account the characteristics of metabolism and the acid-base reaction of urine. The use of the drug in urolithiasis and crystalluria does not depend on the composition of the stones and the pH of the urine. The drug is effective in oxalate, urate, phosphate urolithiasis. When you stop taking the drug Cyston® tablets, the “withdrawal” syndrome is not observed. In elderly patients and patients with renal insufficiency, dose adjustment of the drug is not required. Special measures for skipping one or more doses of the drug are not required. If the patient misses taking the drug one or more times, you should continue taking the drug according to the scheme recommended in the instructions, without doubling the dose. Special precautions for the destruction of unused medicinal product are not required. Influence on the ability to drive a car and other mechanisms The drug does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving a car and other vehicles, working with moving mechanisms, the work of a dispatcher / operator, etc.). Pharmacological action Means for dissolving urinary calculi. Code ATX G04BC. Pharmacodynamics The complex of biologically active substances that make up Cystoy® has a diuretic, antispasmodic, litholytic, antimicrobial and anti-inflammatory effect. Cystone regulates the crystal-colloidal balance in dysmetabolic nephropathy, prevents oversaturation of lithogenic substances. It inhibits the formation of stones by reducing the concentration in the urine of substances such as oxalic acid, calcium, hydroxyproline, etc., which contribute to the formation of stones. Increases the content of elements that inhibit the formation of stones (sodium, magnesium, potassium). By acting on mucin, Cyston promotes the disintegration of calculi, leads to their demineralization, which facilitates their expulsion. Prevents the accumulation of particles around the core of the stone, which prevents its further growth. The litholytic effect of the drug does not depend on the pH of the urine. By stimulating diuresis and relaxing the smooth muscles of the urinary tract, Cyston promotes the removal of oxalate, phosphate, urate and small stones from the urinary tract. Its antispasmodic and anti-inflammatory action relieves ureteral colic and relieves the symptoms of painful urination. Cystone has a bacteriostatic and bactericidal effect, more pronounced against Klebsiella spp., Pseudomonas aeruginosa, Escherichia coli and other gram-negative bacteria. Its antimicrobial activity is useful in the treatment of urinary tract infections. Pharmacokinetics There are no data on the pharmacokinetics of the multicomponent herbal drug Cyston® in tablet dosage form. The activity of the drug is due to the mutually reinforcing combined action of its components, which is typical for herbal medicines. Since the activity of the drug cannot be fully attributed to any one compound, pharmacokinetic studies of multicomponent herbal preparations, including Cyston® tablets, are not feasible. Indications for useComplex therapy of urolithiasis (oxalate, phosphate and urate stones), prevention of postoperative recurrence of stones, crystalluria and urinary tract infections. Method of application and doses The use of the drug Cyston® is recommended against the background of increased fluid intake up to 2 – 2.5 liters per day. Inside, after eating. Doses for adults and adolescents: For urolithiasis and crystalluria: 2 tablets 2 to 3 times a day for 4 to 6 months or until stones pass or crystalluria symptoms subside. To prevent recurrence after external lithotripsy, surgical removal or spontaneous passage of stones: 2 tablets 2-3 times a day for the first month, then 1 tablet 2 times a day for 4-5 months. In the complex therapy of urinary tract infections (cystitis, urethritis, pyelonephritis and others): 2 tablets 2 times a day, the duration of the course of treatment is 2-3 weeks or until the clinical symptoms and laboratory tests normalize. Children over 12 years old: with urolithiasis and crystalluria, in the complex therapy of urinary tract infections: 1 tablet 2-3 times a day. The terms of treatment can be extended depending on the severity of the disease on the recommendation of a doctor. Use during pregnancy and lactation The use of the drug is not recommended during pregnancy and during breastfeeding (due to insufficient data on the study of the efficacy and safety of the drug in these conditions). If necessary, the use of the drug during lactation, breastfeeding should be discontinued. Contraindications Hypersensitivity to the components of the drug. Acute pain in the kidneys and urinary tract. Children’s age up to 12 years. The use of the drug is not recommended for stones larger than 9 mm in diameter due to the threat of obstruction. CompositionEach tablet contains: Active Ingredients: Extracts*: bicarp leaves (Didymocarpus pedicellata) 65 mg; saxifrage reed roots (Saxifraga Ligulata) 49 mg; madder cordifolia roots (Rubia cordifolia) 16 mg; satiety membranous rhizome (Cyperus scariosus) 16 mg; rough strawflower seeds (Achyranthes aspera) 16 mg; Onosma bracteatum aerial part (Onosma bracteatum) 16 mg; ashy vernia whole plant (Vemonia cinerea) 16 mg; Powders*: lime silicate (Hajrul Yahood Bhasma) 16 mg; Shilajeet purified (Shilajeet purified) 13 mg, * – which are steam-treated with an extract of a mixture of the following plant materials (in equal amounts in a ratio of 1:10 to water): fragrant basil aerial part (Ocimum basilicum), horse bean seeds (Dolichos biflorus), tribulus terrestris (Tribulus terrestris), shy mimosa seeds (Mimosa pudica), fragrant pavonia whole plant (Pavonia odorata), horsetail whole plant (Equisetum arvense), teak tree seeds (Tectona grandis). Excipients: microcrystalline cellulose, sodium carboxymethylcellulose, crospovidone, colloidal silicon dioxide, magnesium stearate. Overdose To date, cases of overdose have not been identified, so the symptoms of overdose have not been described. To avoid overdose, strictly follow the instructions for use. Treatment in case of accidental overdose with Cyston®: symptomatic. Interaction with other drugs The use of the drug with antibiotics improves the effectiveness of therapy. Cyston® increases the bioavailability of norfloxacin. When combined with cotrioxazole in an animal experiment, Cyston® delayed the absorption of sulfamethoxazole, significantly increasing its bioavailability, and accelerated the absorption of trimethoprim, without significantly affecting its bioavailability. When using these drugs simultaneously with Cyston®, their dose may need to be adjusted. Side effects Allergic reactions. If any of the side effects listed in the instructions worsen, or you notice any other side effects not listed in the instructions, tell your doctor. Storage conditionsStore at a temperature from + 10 °С to + 30 °С, in a place protected from moisture. Keep out of the reach of children. Buy Cyston tablets No. 100 Price for Cyston tablets No. 100 Instructions for use for Cyston tablets No. 100
The code | 658 |
---|---|
Barcode | 8 901 138 030 711 |
Active substance | herbal extract |
Manufacturer | Himalaya Drag Company, India |
Importer | IOOO Interfarmaks 223028 Minsk region, Minsk district, Zhdanovichsky s / s, ag. Zhdanovichi, st. Star, 19a-5, room. 5-2 |
Be the first to review “Cyston tablets №100” Cancel reply
Related products
In diseases of the urinary tract
$32.00
In diseases of the urinary tract
$45.00
In diseases of the urinary tract
Phytolysin paste for internal use in tubes 100g in a pack. #1
$20.00
Reviews
There are no reviews yet.